Monday, May 21, 2018
Company News: Page (1) of 1 - 02/14/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Worldwide Business with kathy ireland®: See 3D Signatures Introduce Their Genomic Imaging Breakthrough for Precision Medicine

(February 14, 2018)

Los Angeles, CA - February 14, 2018 - Worldwide Business with kathy ireland® is pleased to announce an exclusive story featuring Jason Flowerday, CEO of 3D Signatures, discussing the company's technological breakthrough in terms of personalized medicine.

3D Signatures is a novel personalized medicine company with proprietary software that can analyze a patient's chromosomal arrangement -- or signature -- through a simple, non-invasive blood test or tissue sample. This measures disease stage and genomic stability, as well as drug efficacy and potential side effects. Unlike most diagnostic companies, 3D Signature's proprietary imaging software goes beyond identifying whether a patient suffers from a specific disease or condition. The company's analytics platform tells doctors how to personalize treatment and best manage the disease for each individual patient. Based on Dr. Sabine Mai's groundbreaking research, 3D Signatures is the first and only company to understand and quantify normal versus disease state telomere arrangement, turning this into usable, predictable, reliable and highly valuable information that can improve patient outcomes. This disruptive technology platform is fundamentally different from conventional diagnostic methods and could represent an entirely new class of biomarkers for diseases like cancer and Alzheimer's. The company was founded in 2012 and is headquartered in Toronto, Ontario.

Flowerday says that 3DSignatures' new technology has amazing potential for cancer and Alzheimer's patients. He explains, "What we've been able to do is develop a proprietary, biomarker-based approach to personalizing medicine. As patients have cancer and Alzheimer's disease, we know that their genes and DNA go through changes. We've actually been able to look at those changes, analyze them and really make sense about how one patient's cancer is different from another patient's cancer. It really represents a new novel approach to personalizing medicine, and we're really excited."

JL Haber, Vice President of Programming for Worldwide Business with kathy ireland®, is proud to feature 3DSignatures. He says, "What's so exciting about the field of medicine is that it's advancing every day. 3D Signatures is a company that's dedicated to personalizing treatment for disease, so that each patient's unique disease is managed in the best way. This innovative company's medical software is absolutely changing the way medical practitioners evaluate and treat their patients. We're thrilled to have 3D Signatures on our show."

For more information about 3D Signatures, visit and tune in to Fox Business Network as sponsored content on Saturday, February 17, 2018 at 5:30pm EST and Bloomberg International on Sunday, February 25, 2018 at 7:00am GMT and 10:00am D.F.

About Worldwide Business with kathy ireland®

Worldwide Business with kathy ireland® is a weekly half-hour show featuring global executives sharing their business insights and framing the opportunities shaping their industries. Hosted by business mogul and one of the world’s greatest corporate leaders, Kathy Ireland interviews some of the brightest minds in business today. The show broadcasts on Fox Business Network as part of their sponsored content line up and globally on Bloomberg International. Worldwide Business with kathy ireland® extends beyond the weekly on-air program with digital content delivered on various video platforms and across social media.

Visit for detailed airing schedules or check local listings.

For more up to date information visit us on Twitter and Facebook.

Media Contact
Company Name: Worldwide Business with kathy ireland
Contact Person: Gila Stern | Communications Director
Email: [email protected]
Phone: 561-325-7700 x529
Country: United States

Page: 1

Related Keywords:Business,
Related Sites: IBN - Business ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Sanofi: Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis
  • Global Molecular Diagnostics Markets, 2016-2024 - Focus on Infectious Disease Testing, Blood Screening, Cancer Screening & Other Applications
  • Global Sleep Apnea Diagnostic and Therapeutic Devices Strategic Business Report 2018
  • Global Sleep Apnea Diagnostic and Therapeutic Devices: 2016/18-2024 Strategic Business Analysis & Forecast Report - mHealth-Enabled Sleep Tracking Devices Gain Ground
  • Blavatnik Family Foundation Provides $10 Million Gift to Mount Sinai to Support Mission of Advancing Women’s Health

  • Oasmia Pharmaceutical Completes Spin-off of Veterinary Oncology Assets to Wholly Owned US Subsidiary, AdvaVet, Inc.
  • HedgePath Pharmaceuticals Announces Additional Expanded Patent Coverage
  • Dr. Haydee Gonzalez Hidalgo joins The Oncology Institute of Hope and Innovation
  • eClinical Solutions Market Size Is Projected To Reach $13 Billion By 2024
  • Multiple New Vendor GPO Awards Position Keneric Healthcare to Increase Its Market Reach for Their Advanced Wound Care and Patient Cleansing Products Lines

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines